UNIGE document Scientific Article
previous document  unige:1937  next document
add to browser collection
Title

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis
Authors
Reny, Jean-Luc
De Moerloose, Philippe
Dauzat, M.
Fontana, Pierre
Published in Journal of Thrombosis and Haemostasis. 2008, vol. 6, no. 3, p. 444-50
Abstract BACKGROUND: PFA-100 is a point-of-care assay that evaluates platelet reactivity in high-shear-stress conditions by measuring the closure time (CT) of a membrane aperture. When determined with a collagen/epinephrine cartridge (CEPI), the CT is usually prolonged by aspirin. Studies of the predictive value of a short PFA-100CT(CEPI) for ischemic events in aspirin-treated patients have given variable results. OBJECTIVES: To conduct a systematic review and meta-analysis of studies on the clinical predictive value of a short PFA-100CT(CEPI) in aspirin-treated cardiovascular patients. PATIENTS AND METHODS: Relevant studies were identified by scanning electronic databases. Studies were selected if they included aspirin-treated patients with symptomatic atherosclerosis, measured the PFA-100CT(CEPI), used a CT cut-off value to define aspirin 'responders' and 'non-responders', and reported ischemic events. RESULTS: We selected seven non-prospective studies (1466 patients) and eight prospective studies (1227 patients). In non-prospective studies, the PFA-100CT(CEPI) was performed after the ischemic clinical endpoint, and a publication bias was identified. In prospective studies, the global odds ratio (OR) for the recurrence of an ischemic event in 'aspirin non-responders' relative to 'aspirin responders' was 2.1 [95% confidence interval (CI) 1.4-3.4, P < 0.001]. Pooled analysis with a random effect model revealed no heterogeneity (Q Cochran P = 0.36 and I(2) = 9.4%). CONCLUSIONS: A short PFA-100CT(CEPI) is associated with increased recurrence of ischemic events in aspirin-treated cardiovascular patients. This finding needs to be confirmed in stable ischemic patients, and the PFA-100CT(CEPI) cut-off needs to be refined in these patients.
Keywords Anti-Inflammatory Agents, Non-Steroidal/pharmacology — Aspirin/pharmacology — Blood Platelets/cytology — Cardiology/methods — Clinical Trials as Topic — Humans — Myocardial Ischemia — Platelet Activation — Platelet Aggregation — Platelet Aggregation Inhibitors/pharmacology — Predictive Value of Tests — Prospective Studies — Time Factors
Identifiers
PMID: 18194417
Full text
Article (Author postprint) (188 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://www3.interscience.wiley.com/cgi-bin/fulltext/119422620/HTMLSTART
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Research groups Anticorps antiphospholipides (12)
Geneva Platelet Group (13)
Citation
(ISO format) 		RENY, Jean-Luc et al. Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis. In: Journal of Thrombosis and Haemostasis, 2008, vol. 6, n° 3, p. 444-50. https://archive-ouverte.unige.ch/unige:1937

224 hits

1 download

Contact an author

Update request

Update

Deposited on : 2009-06-10

Export document
Format :
Citation style :